Anand Mehra, Director at Aclaris Therapeutics, Inc. (ACRS), sold 750,000 shares at $28.25 ($21.2M) on 2017-01-10, disclosed to the SEC on 2017-01-12.
Open-market sale of $21.2M ACRS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ONCE | SELL | 2017-07-26 | $14.9M | — | Filing → |
| ONCE | SELL | 2017-06-22 | $410K | — | Filing → |
| ONCE | SELL | 2017-03-06 | $2.0M | — | Filing → |